Valeo Pharma Inc.
- Home
- Companies
- Valeo Pharma Inc.
- Products
- Atectura - Breezhaler
Atectura - Breezhaler
Next generation dual therapy LABA/ICS. Partner with Novartis Pharma Canada.
Most popular related searches
Value Proposition
Next Generation Dual THERAPY
in asthma
LABA/ICS
One Inhalation Once a Day
Indacaterol (as acetate)
Mometasone Furoate
TOGETHER IN BREEZHALER® Device
Available Strengths
150 mcg/80 mcg DIN 02498685
150 mcg/160 mcg DIN 02498707
150 mcg/320 mcg DIN 02498693